PBM
Psyence Biomedical Ltd.
NASDAQ · Healthcare · Biotechnology · CA
$6.63
+4.83%Sep 14, 2026, 23:48 UTC
Psyence Biomedical Ltd. announced the formation of Texas Ibogaine Research Corporation, a Texas-based U.S. vehicle to coordinate its ibogaine development activities including supply, regulatory engagement and potential clinical development.
Source:Jun 3, 2026, 00:00 UTC
Psyence Labs Ltd. disclosed a 30.1% stake in Psyence Biomedical Ltd. via a 13D/G filing.